- Home
- SUNC vs OPCH Comparison
SUNC vs OPCH Comparison
Compare SUNC & OPCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$24.23
Company Overview
Basic Information| Metric | SUNC | OPCH |
|---|---|---|
| Founded | 2000 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Nursing Services |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.5B |
| IPO Year | 2025 | 1996 |
Fundamental Metrics
Financial Performance| Metric | SUNC | OPCH |
|---|---|---|
| Price | $78.68 | $24.23 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 7 |
| Target Price | ★ $61.00 | $36.57 |
| AVG Volume (30 Days) | 373.7K | ★ 1.7M |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | ★ 5.74% | N/A |
| EPS Growth | N/A | ★ 3.25 |
| EPS | ★ 2.89 | 0.29 |
| Revenue | ★ $25,201,000,000.00 | $4,998,202,000.00 |
| Revenue This Year | $65.29 | $7.21 |
| Revenue Next Year | $0.84 | $8.55 |
| P/E Ratio | ★ $26.70 | $83.90 |
| Revenue Growth | 11.05 | ★ 16.17 |
| 52 Week Low | $47.00 | $18.01 |
| 52 Week High | $78.85 | $36.80 |
Technical Indicators
Market Signals| Indicator | SUNC | OPCH |
|---|---|---|
| Relative Strength Index (RSI) | 55.92 | 61.74 |
| Support Level | $74.68 | $22.97 |
| Resistance Level | $78.21 | $24.83 |
| Average True Range (ATR) | 1.72 | 0.54 |
| MACD | -0.04 | -0.03 |
| Stochastic Oscillator | 59.71 | 92.52 |
Price Performance
Historical Comparison SUNC
OPCH
About SUNC SunocoCorp LLC
SunocoCorp LLC is a publicly traded limited liability company that owns a direct limited partner interest in Sunoco LP. It engages in the management and distribution of fuel products. It operates through the following segments: Fuel Distribution, Pipeline Systems, and Terminals and Refinery.
About OPCH Option Care Health Inc.
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders, among others. The Company operates in one segment, infusion services.